No Data
No Data
No Data
No Data
No Data
Chicago Capital Management LLC Takes $10.17 Million Position in Turning Point Therapeutics, Inc. (NASDAQ:TPTX)
Chicago Capital Management LLC acquired a new stake in shares of Turning Point Therapeutics, Inc. (NASDAQ:TPTX – Get Rating) in the 2nd quarter, Holdings Channel.com reports. The institutional inves
Financial News LiveOct 10, 2022 10:51 ET
Versor Investments LP Takes $47.04 Million Position in Turning Point Therapeutics, Inc. (NASDAQ:TPTX)
Versor Investments LP bought a new stake in Turning Point Therapeutics, Inc. (NASDAQ:TPTX – Get Rating) in the second quarter, according to the company in its most recent Form 13F filing with the Se
Financial News LiveOct 9, 2022 12:21 ET
Brinker Capital Investments LLC Buys Shares of 3,167 Turning Point Therapeutics, Inc. (NASDAQ:TPTX)
Brinker Capital Investments LLC bought a new stake in Turning Point Therapeutics, Inc. (NASDAQ:TPTX – Get Rating) in the second quarter, according to the company in its most recent Form 13F filing w
Defense WorldOct 9, 2022 04:51 ET
Turning Point Therapeutics, Inc. (NASDAQ:TPTX) Shares Sold by Amalgamated Bank
Amalgamated Bank cut its position in Turning Point Therapeutics, Inc. (NASDAQ:TPTX – Get Rating) by 7.0% during the first quarter, according to its most recent Form 13F filing with the SEC. The firm
Defense WorldOct 9, 2022 04:12 ET
Turning Point Therapeutics, Inc. (NASDAQ:TPTX) Given Average Rating of "Hold" by Brokerages
Turning Point Therapeutics, Inc. (NASDAQ:TPTX – Get Rating) has received an average rating of "Hold" from the twelve brokerages that are covering the stock, Marketbeat reports. Eight research analys
Defense WorldSep 19, 2022 02:22 ET
ProShare Advisors LLC Sells 3,250 Shares of Turning Point Therapeutics, Inc. (NASDAQ:TPTX)
ProShare Advisors LLC reduced its position in Turning Point Therapeutics, Inc. (NASDAQ:TPTX – Get Rating) by 19.1% in the 1st quarter, HoldingsChannel.com reports. The fund owned 13,760 shares of th
Defense WorldSep 5, 2022 04:11 ET
No Data
No Data